Issuu on Google+

A Special Issue for the XXI World Congress of Neurology

EUROPEAN JOURNAL OF

NEUROLOGY THE OFFICIAL JOURNAL OF THE EUROPEAN FEDERATION OF NEUROLOGICAL SOCIETIES

N JOURNAL OF

ROLOGY

EUROPEAN FEDERATION OF NEUROLOGICAL SOCIETIES

Contents: 2 EFNS Membership 4 Top Downloaded EFNS Guidelines 5 Top Cited EFNS Guidelines 6

Top Downloaded Journal Articles

8

Top Cited Journal Articles

10 Free Access to the September Issue 11 EFNS Resources 12

Wiley Neurology

The EUROPEAN FEDERATION OF NEUROLOGICAL SOCIETIES, comprised of 45 European national neurological societies, 9 associate member societies and individual members, seeks to: •

 Advance neurology as an independent specialty covering all diseases of the nervous system

Make neurology universally available in Europe

Support and disseminate neurological research

Provide and support neurological teaching

Represent European neurology politically

All members of the European national neurological member societies are automatically ordinary members of the EFNS. All EFNS members do have free online access to the online learning platform eBrain and the European Journal of Neurology. Members pay a reduced fee at future congresses (Istanbul, Turkey 2014 & Berlin, Germany 2015). They do have the opportunity to apply for educational grants. If registered to www.efns.org, the latest issue of the newsletter www.neuropenews.org is sent to them. EFNS members should have free access to all the articles listed in this special issue. Please visit Booth #13 if you have trouble accessing.

For more on EFNS, visit our webpage. Become a member of EFNS here.

Follow our social media pages:

2

A Special Issue for the XXI World Congress of Neurology

3

Top Downloaded EFNS GUIDELINES OF ALL TIME

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision September 2010 N. Attal, G. Cruccu, R. Baron, et al. Background:

 is second European Federation of Neurological Societies Task Force aimed at updating Th the existing evidence about the pharmacological treatment of neuropathic pain since 2005.

METHODS:

 Studies were identified using the Cochrane Database and Medline. Trials were classified according to the aetiological condition. All class I and II randomized controlled trials (RCTs) were assessed; lower class studies were considered only in conditions that had no top-level studies. Treatments administered using repeated or single administrations were considered, provided they are feasible in an outpatient setting.

EFNS guidelines for the diagnosis and management of Alzheimer’s disease October 2010 J. Hort, J. T. O’Brien, G. Gainotti, et al. Background:

In 2008 a task force was set up to develop a revision of the European Federation of the Neurological Societies (EFNS) guideline for the diagnosis and management of Alzheimer’s disease (AD) and other disorders associated with dementia, published in early 2007. The aim of this revised international guideline was to present a peer-reviewed evidencebased statement for the guidance of practice for clinical neurologists, geriatricians, psychiatrists, and other specialist physicians responsible for the care of patients with AD. Mild cognitive impairment and non-Alzheimer dementias are not included in this guideline.

METHODS:

The task force working group reviewed evidence from original research articles, metaanalysis, and systematic reviews, published before May 2009. The evidence was classified and consensus recommendations graded (A, B, or C) according to the EFNS guidance. Where there was a lack of evidence, but clear consensus, good practice points were provided.

EFNS guideline on the management of status epilepticus in adults March 2010 H. Meierkord, P. Boon, B. Engelsen, et al.

4

Background:

 e objective of the current article was to review the literature and discuss the degree of Th evidence for various treatment strategies for status epilepticus (SE) in adults.

METHODS:

 proposed guideline with specific recommendations was drafted for circulation to all A panel members. Each panellist studied and commented in writing on each successive guideline draft, revised to progressively accommodate the panel consensus. Where there was a lack of evidence but consensus was clear, we have stated our opinion as good practice points (GPP). In a further step, the draft of the guideline was circulated to all members of the EFNS scientific committee for their comments. These have been incorporated into the current version of the guideline.

A Special Issue for the XXI World Congress of Neurology

Top Cited EFNS GUIDELINES 2011-2013

1. Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force January 2011 M. J. Titualaer, R. Soffietti, J. Dalmau, et al.

2. EFNS guidelines on diagnosis and treatment of primary dystonias January 2011 A. Albanese, F. Asmus, K. P. Bhatia, et al.

3. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force March 2012 P. Andersen, S. Abrahams, G. Boarsio, et al.

4. Treatment of medication overuse headache – guideline of the EFNS headache panel September 2011 S. Evers, R. Jensen

5. EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders February 2011 J. M. Burgunder, L. Schoels, J. Baets, et al.

Impact Factor

4.162

For more EFNS GUIDELINES that contributed to the new Journal Impact Factor of 4.162, visit our Most Cited page!

5

Top Downloaded Articles of all time from European Journal of Neurology

Stroke incidence and prevalence in Europe: a review of available data June 2006 T. Truelsen, B. Piechowski-Jóźwiak, R. Bonita, et al. Abstract:

 eliable data on stroke incidence and prevalence are essential for calculating the R burden of stroke and the planning of prevention and treatment of stroke patients. In this study we have reviewed the published data from EU countries, Iceland, Norway, and Switzerland, and provide WHO estimates for stroke incidence and prevalence in these countries.

Complex regional pain syndromes: new pathophysiological concepts and therapies May 2010 C. Maihöfner, F. Seifert, K. Markovic Abstract:

 omplex regional pain syndrome (CRPS), formerly known as Sudeck’s dystrophy and C causalgia, is a disabling and distressing pain syndrome. We here provide a review based on the current literature concerning the epidemiology, etiology, pathophysiology, diagnosis, and therapy of CRPS.

Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis April 2012 M.B. D’hooghe, P. Haentjens, G. Nagels, et al.

6

Background:

 ertain lifestyle factors might influence disease activity in multiple sclerosis (MS). C The purpose of this study is to investigate the consumption of alcoholic beverages, caffeinated drinks, fish and cigarette smoking in relation to disability progression in relapsing onsent and progressive onset MS.

Methods:

 e conducted a cross-sectional survey amongst individuals with MS, registered by the W Flemish MS society in Belgium. A time-to-event analysis and Cox proportional-hazard regression were performed with time to Expanded Disability Status Scale (EDSS) 6 (requiring a cane or support to walk for a distance of 100 m) as outcome measure. Hazard ratios for the time from onset and from birth were adjusted for age at onset, gender and immunomodulatory treatment.

A Special Issue for the XXI World Congress of Neurology

Top Downloaded Articles — year to date from European Journal of Neurology

1. The epidemiology of multiple sclerosis in Europe July 2006 M. Pugliattu, G. Rosati, H. Carton, et al. 2. The economic cost of brain disorders in Europe January 2012 J. Olesen, A. Gustavsson, M. Svensson, et al. 3. Association between multiple sclerosis and chronic periodontitis: a population based pilot study July 2013 J. J. Sheu, H. C. Lin 4. Correlation of anatomy and function in medulla oblongata infarction February 2009 C. Eggers, G. R. Fink, W. Moller-Hartmann, et al. 5. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer’s dementia in a randomized placebo-controlled double-blind study September 2006 M. Mazza, A. Capuano, P. Bria, et al.

7

Top Cited Articles 2011-2013 from European Journal of Neurology

These are the top journal papers that contributed to our 2012 Impact Factor – 4.162 The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis 2011 V. Devonshore, Y. Lapierre, R. Macdonnell, et al. Background:

 ost disease-modifying therapies (DMTs) for multiple sclerosis (MS) are self-injectable M medications that must be taken on an ongoing basis to reduce disease activity. Thus, adherence to therapy becomes an important challenge that must be addressed to maximize benefits of therapy. This study evaluated rates of adherence to prescribed treatment and explored factors affecting adherence among patients with relapsingremitting MS.

Improved language performance subsequent to low-frequency rTMS in patients with chronic non-fluent aphasia post-stroke 2011 C. H. S. Barwood, B. E. Murdoch, B. M. Whelan, et al. Background:

L ow-frequency repetitive transcranial magnetic stimulation (rTMS) has emerged as a potential for neurorehabilitation and remediation of language in chronic non-fluent aphasia post-stroke. Inhibitory (1 Hz) rTMS has been applied to homologous language sites to facilitate behavioural language changes. Improvements in picture-naming and speech output over time have been reported.

Catechols in post-mortem brain of patients with Parkinson disease May 2011 D.S. Goldstein, P. Sullivan, C. Holmes, et al.

8

Background:

 ihydroxyphenylacetaldehyde (DOPAL), a cytotoxic metabolite of dopamine, is the focus D of the ‘catecholaldehyde hypothesis’ about the pathogenesis of Parkinson disease. This study explored whether DOPAL is detectable in human striatum – especially in the putamen (Pu), the main site of dopamine depletion in Parkinson disease – and is related to other neurochemical indices of catecholamine stores and metabolism in Parkinson disease.

Methods:

 utamen, caudate (Cd), and frontal cortex (Ctx) catechols were measured in tissue from P patients with pathologically proven end-stage Parkinson disease (N = 15) and control subjects (N = 14) of similar age with similar post-mortem intervals.to other neurochemical indices of catecholamine stores and metabolism in Parkinson disease.

A Special Issue for the XXI World Congress of Neurology

Top Cited Articles 2011-2013 from European Journal of Neurology

1. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex (R)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis September 2011 A. Novotna, J. Mares, S. Ratcliffe, et al. 2. The cost of headache disorders in Europe: the Eurolight project May 2012 M. Linde, A. Gustavsson, L.J. Stovner, et al. 3. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache January 2011 R. B. Grande, K. Aaseth, J.S. Benth, et al. 4. Cortical subarachnoid haemorrhage in the elderly: a recurrent event probably related to cerebral amyloid angiopathy April 2011 N. Raposo, A. Viguier, V. Cuvinciuc, et al. 5.  Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis February 2011 S. Belachew, R. Phan-Ba, E. Bartholome, et al.

9

VOLUME 20 • NUMBER 9 • SEPTEMBER 2013 European Journal of Neurology Official Journal of the European Federation of Neurological Societies Volume 20 Issue 9 September 2013

Contents Editorials 1223 Emergency call from gynecologists: how to treat restless legs syndrome during pregnancy? C. Trenkwalder 1225 Screening tools for fitness to drive after traumatic brain injury and stroke H. Devos and C. A. Hawley

CME Article 1227 Prediction of on-road driving ability after traumatic brain injury and stroke P. M. Aslaksen, M. Ørbo, R. Elvestad, C. Schäfer and A. Anke

Original Articles

Editorials

1241 Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series M. Dostal, C. Weber-Schoendorfer, J. Sobesky and C. Schaefer 1247 Young adult ischaemic stroke related acute symptomatic and late seizures: risk factors R. Roivainen, E. Haapaniemi, J. Putaala, M. Kaste and T. Tatlisumak 1256 The association between asymptomatic coronary artery disease and CHADS2 and CHA2DS2-VASc scores in patients with stroke M.-J. Cha, H. S. Lee, Y. D. Kim, H. S. Nam and J. H. Heo 1264 Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis A. Kardys, B. Weinstock-Guttman, M. Dillon, M. W. Masud, N. Weinstock, N. Mahfooz, J. K. Lang, A. Weinstock, N. Lincoff, R. Zivadinov and M. Ramanathan 1272 Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis R. Nakata, M. Motomura, T. Masuda, H. Shiraishi, M. Tokuda, T. Fukuda, T. Ando, T. Yoshimura, M. Tsujihata and A. Kawakami

1. Emergency  call from gynecologists: how to treat restless legs syndrome during pregnancy? (pages 1223–1224) Short Communication

1325 The effects of multidisciplinary rehabilitation in patients with early-to-middle-stage Huntington’s disease: a pilot study J. A. Thompson, T. M. Cruickshank, L. E. Penailillo, J. W. Lee, R. U. Newton, R. A. Barker and M. R. Ziman

Volume 20 • Number 9 • September 2013 • pp 1223–1330

Review Article 1234 Anaemia and cognitive performances in the elderly: a systematic review M. Andro, P. Le Squere, S. Estivin and A. Gentric

1277 Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage D. Rodriguez-Luna, S. Piñeiro, M. Rubiera, M. Ribo, P. Coscojuela, J. Pagola, A. Flores, M. Muchada, B. Ibarra, P. Meler, E. Sanjuan, M. HernandezGuillamon, J. Alvarez-Sabin, J. Montaner and C. A. Molina 1284 Are 25 SNPs from the CARDIoGRAM study associated with ischaemic stroke? H. Lövkvist, M. Sjögren, P. Höglund, G. Engström, C. Jern, S. Olsson, J. G. Smith, B. Hedblad, G. Andsberg, H. Delavaran, K. Jood, U. Kristoffersson, B. Norrving, O. Melander and A. Lindgren 1292 Predicting multiple sclerosis following isolated optic neuritis in children N. Heussinger, E. Kontopantelis, O. Rompel, M. Paulides and R. Trollmann 1297 Neuropsychological course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis C. Frisch, M. P. Malter, C. E. Elger and C. Helmstaedter 1305 Factors associated with post-stroke anger proneness in ischaemic stroke patients S. Choi-Kwon, K. Han, K.-H. Cho, S. Choi, M. Suh, H.-W. Nah and J. S. Kim 1311 High resolution MRI difference between moyamoya disease and intracranial atherosclerosis Y. J. Kim, D. H. Lee, J. Y. Kwon, D. W. Kang, D. C. Suh, J. S. Kim and S. U. Kwon 1319 Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy E. Gómez-Tortosa, R. Guerrero-López, E. Gil-Neciga, E. Franco, T. del Ser, A. Jiménez Escrig, J. Pérez-Pérez and M. J. Sainz

European Journal of Neurology

Free Access to the european Journal of Neurology’s September Issue

EUROPEAN JOURNAL OF

NEUROLOGY THE OFFICIAL JOURNAL OF THE EUROPEAN FEDERATION OF NEUROLOGICAL SOCIETIES

Miscellaneous i Calendar

2. Screening tools for fitness to drive after traumatic brain injury and stroke (pages 1225–1226) Cover insert: Examples of asymmetric perisylvian atrophy in patients diagnosed as having Lewy body disease (left) and dementia of the Alzheimer type (right). See Gómez-Tortosa et al. Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy. European Journal of Neurology 2013; 20: 1319–1324. For submission instructions, subscription and all other information, visit www.europeanjournalofneurology.com Printed in Singapore by Markono Print Media Pte Ltd.

CME Article

ISSN 1351-5101

1. Prediction of on-road driving ability after traumatic brain injury and stroke (pages 1227–1233)

Review Article 1. Anaemia and cognitive performances in the elderly: a systematic review (pages 1234–1240)

Original Articles

1. Pregnancy  outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series (pages 1241–1246) 2. Young adult ischaemic stroke related acute symptomatic and late seizures: risk factors (pages 1247–1255) 3. The  association between asymptomatic coronary artery disease and CHADS2 and CHA2DS2-VASc scores in patients with stroke (pages 1256–1263) 4. Cholesterol  affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis (pages 1264–1271) 5. Thymus  histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis (pages 1272–1276) 6. Impact  of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage (pages 1277–1283) 7. Are 25 SNPs from the CARDIoGRAM study associated with ischaemic stroke? (pages 1284–1291) 8. Predicting multiple sclerosis following isolated optic neuritis in children (pages 1292–1296) 9. Neuropsychological  course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis (pages 1297–1304)

10. Factors associated with post-stroke anger proneness in ischaemic stroke patients (pages 1305–1310) 11. High  resolution MRI difference between moyamoya disease and intracranial atherosclerosis (pages 1311–1318) 12. Plasma  progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy (pages 1319–1324)

Short Communication

1. The effects of multidisciplinary rehabilitation in patients with early-to-middle-stage Huntington’s disease: a pilot study (pages 1325–1329)

Letters to the Editor

1. Pure psychiatric presentation of Fragile X-associated tremor/ataxia syndrome (pages e113–e114) 2. Colony stimulation factor 1 receptor (CSF1R) is not a common cause of multiple sclerosis (pages e115–e116) 3. Reporting a new mutation at the SLC20A2 gene in a Brazilian family with idiopathic basal ganglia calcification – Correction (page e117)

Book Review 1. Proteopathic Seeds and Neurodegenerative Diseases (page e118)

10

Journal and EFNS Resources

The new European Journal of Neurology app!

Books from EFNS

For the latest developments, optimized browsing, and a great reading experience.

http://bit.ly/EFNSbundle

E-learning from EFNS: hanging the face of learning in the Neurosciences ebrain represents the world’s largest, most comprehensive C web-based training resource in clinical neuroscience. This exciting new interactive online learning program designed to support training and continuous professional development for clinical neuroscience trainees, consultants and non-specialists. Ebrain is free of charge for all EFNS members.

A Special Issue for the XXI World Congress of Neurology

11

Wiley Neurology News To see our ENTIRE portfolio of journals, visit http://www.wiley.com/WileyCDA/Section/id-818417.html

Follow us on social media! Wiley Neurology: http://facebook.com/wileyneurology http://twitter.com/wileyneuro

Wiley Health: http://facebook.com/wileyhealth http://twitter.com/wiley_Health

12


EUROPEAN JOURNAL OF NEUROLOGY for the XXI World Congress of Neurology